Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9 USD | -3.64% | -4.05% | -30.77% |
Mar. 26 | Enveric Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 19 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 5M | Capitalization | 6.56M |
---|---|---|---|---|---|
Net income 2024 * | -18M | Net income 2025 * | -13M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.31 x |
P/E ratio 2024 * |
-0.43
x | P/E ratio 2025 * |
-0.88
x | Employees | 7 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.94% |
1 day | -3.64% | ||
1 week | -4.05% | ||
Current month | -10.00% | ||
1 month | -14.29% | ||
3 months | +1.98% | ||
6 months | -52.63% | ||
Current year | -30.77% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Tucker
CEO | Chief Executive Officer | 55 | 21-09-15 |
Kevin Coveney
DFI | Director of Finance/CFO | 60 | 23-03-12 |
Jillian Hagel
CTO | Chief Tech/Sci/R&D Officer | 45 | 21-09-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Webb
CHM | Chairman | 66 | 22-06-12 |
Joseph Tucker
CEO | Chief Executive Officer | 55 | 21-09-15 |
Frank Pasqualone
BRD | Director/Board Member | 68 | 22-07-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.9 | -3.64% | 88,444 |
24-04-24 | 0.934 | +4.08% | 184,679 |
24-04-23 | 0.8974 | +4.23% | 71,434 |
24-04-22 | 0.861 | -2.23% | 110,502 |
24-04-19 | 0.8806 | -6.12% | 131,659 |
Delayed Quote Nasdaq, April 25, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.77% | 6.81M | |
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |
- Stock Market
- Equities
- ENVB Stock